Artemis Real Estate Partners Healthcare Fund III (Parallel-A), L.P.
Raised
Pre-open
Investors
—
Min Invest
None stated
AltStreet Analysis
·Generated from EDGAR primary sources
Artemis Real Estate Partners Healthcare Fund III (Parallel-A), L.P. is a Delaware pooled investment fund vehicle filed by Artemis Real Estate Partners, with Deborah Harmon and Alex Gilbert listed as executive officers. The filing is an original (non-amendment) Form D claiming Rule 506(b) and Section 3(c) exemptions, filed pre-open with total amount sold, investor count, first sale date, and minimum investment all undisclosed. No parent platform or related sibling entities were found in the current database.
This filing sits within the private real estate / healthcare-focused pooled investment fund category, using the common 506(b) private placement exemption paired with an Investment Company Act 3(c) exclusion typical of institutional real estate funds. As a 'Parallel-A' vehicle, it likely runs alongside a primary Fund III entity to accommodate specific investor types; minimum investment and raise figures are not disclosed on the public filing, consistent with early-stage or pre-close institutional offerings.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
Deborah Harmon
Executive Officer · CHEVY CHASE, MD
Alex Gilbert
Executive Officer · CHEVY CHASE, MD
Questions About Artemis Real Estate Partners Healthcare Fund III (Parallel-A), L.P.
Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.
What is Artemis Real Estate Partners Healthcare Fund III (Parallel-A), L.P.?
Artemis Real Estate Partners Healthcare Fund III (Parallel-A), L.P. is an issuer that filed a Form D with the SEC on October 21, 2026. The filing claims 506(b), 3(c).
Is Artemis Real Estate Partners Healthcare Fund III (Parallel-A), L.P. legit?
AltStreet does not rate legitimacy; it reports the public record. Artemis Real Estate Partners Healthcare Fund III (Parallel-A), L.P. filed a Form D with the SEC on October 21, 2026 claiming 506(b), 3(c). A Form D is a notice of an exempt offering, not a review or approval of it. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.
Is Artemis Real Estate Partners Healthcare Fund III (Parallel-A), L.P. registered with or approved by the SEC?
No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that Artemis Real Estate Partners Healthcare Fund III (Parallel-A), L.P. claimed 506(b), 3(c) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.
How much has Artemis Real Estate Partners Healthcare Fund III (Parallel-A), L.P. raised?
Artemis Real Estate Partners Healthcare Fund III (Parallel-A), L.P. reported no amount sold as of the Form D filed October 21, 2026.
Who is selling Artemis Real Estate Partners Healthcare Fund III (Parallel-A), L.P. and how are they paid?
The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly.
Where is Artemis Real Estate Partners Healthcare Fund III (Parallel-A), L.P. located?
The issuer's address on its SEC filings is 5404 Wisconsin Avenue, Suite 1000, Chevy Chase, MD 20815. Its phone number of record is 202-370-7450. It is organized under the laws of Delaware.
Is this your company or fund?
Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.
Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.